It has been demonstrated that high COL5A2 expression promotes the proliferation and invasion of prostate cancer cells (33), is associated with poor prognosis in patients with gastric cancer (34), and promotes the proliferation of colon cancer cells by activating the Wnt/β-catenin signaling pathway (35). This evidence concerns the gene COL5A2 and prostate carcinoma.